Intrexon reported $23.56M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US USD 88.08M 23.66M
Amgen AMGN:US USD 4.61B 695M
Anika Therapeutics ANIK:US USD 46.29M 227K
Arrowhead Research ARWR:US USD 104.68M 10.72M
AstraZeneca AZN:LN USD 10.11B 376M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Immunogen IMGN:US USD 100.73M 7.92M
Intrexon XON:US USD 23.56M 776K
Karyopharm Therapeutics KPTI:US USD 67.45M 465K
Ligand Pharmaceuticals LGND:US USD 70.48M 5.93M
Macrogenics MGNX:US USD 61.12M 5.57M
Mannkind MNKD:US USD 48.85M 6.41M
Merk MRK:US USD 10.32B 624M
Novartis NOVN:VX USD 11.05B 378M
Rigel Pharmaceuticals RIGL:US USD 49.2M 8.39M
Roche Holding ROG:VX 25.06B 4.31B
Sangamo Biosciences SGMO:US USD 82.62M 1.27M
Thermo Fisher Scientific TMO:US USD 9.59B 622M
Veracyte VCYT:US USD 85.72M 445K
Xencor XNCR:US USD 64.3M 1.34M
YTE INCY:US USD 856.61M 171.68M
Ziopharm Oncology ZIOP:US USD 8.53M 2.64M